The report methodology provides a detailed but transparent analysis of key pharmaceutical market trends, including key markets, therapy areas, products and companies. Historical trends are formed over a three-year time horizon and future forecasts are made using a five-year future time period. Thus, the data and analysis relate to the nine-year time horizon from 2003 to 2011.
All data used in outlining historical trends is clearly sourced within the report and any data limitations or additional assumptions are explicitly detailed within the text of the report. Future market forecasts are projected based on both historical trends and future expectations over market conditions and events. The assumptions used to form the basis of key market forecasts are outlined in detail within the text of the report.
KEY FEATURES OF THE REPORT
Comprehensive market trends for key countries, regions, therapy areas, products and companies.
Country profiles for leading pharma markets with market segment trends and 5 year forecasts.
Therapy area profiles for leading therapeutic classes and key products and 2010 sales forecasts.
Detailed profiles of 10 leading pharmaceutical products in 2006, including five year future sales forecasts.
Detailed profiles of 10 leading pharmaceutical companies in 2006, including 2011 sales forecasts.(AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson and Johnson, Merck & Co, Novartis, Pfizer, Roche, Sanofi-Aventis Wyeth)
173 pages long, with 87 figures and 67 tables to illustrate the market trends.
(0 items)
